Triazole derivatives and their use as PDE4 activators
US10385027B2 · kind B2 · utility
2Cited by
0References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 18, 2016 |
| Grant date | Aug 20, 2019 |
| Priority date | — |
| Expiry date | Mar 18, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7028
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I), which are activators of long form cyclic nucleotide phosphodiesterase-4 (PDE4) enzymes, are provided. Methods and uses of these compounds for the treatment or prevention of disorders requiring a reduction of second messenger responses mediated by cyclic 3′,5′-adenosine monophosphate (cAMP) are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.